Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) Here and Clinical Trial Designator - Clinical Trials Not Allowed

RFA-FD-24-020 · FDA

Grant details are part of the paid plan

Award amounts, eligibility, deadlines, and the application link — plus grant alerts the moment new funding posts.